Jeffry Nyman, PhD, professor of Orthopaedic Surgery and research associate professor of Biomedical Engineering, has been named director of the Vanderbilt Center for Bone Biology.
Changes to the bone matrix that occur during aging may point to novel targets for treating osteoporosis.
Sometimes it makes sense to put the cart in front of the horse.
Mustafa Unal, Ph.D., a postdoctoral research fellow at Vanderbilt University School of Medicine, has been selected by the Orthopedic Research Society to receive its 2017 Alice L. Jee Young Investigator Award for work that potentially will improve the clinical assessment of bone strength and quality.
Medical studies have established that people with type 2 diabetes are more susceptible to fractures, but the biological process that weakens their bones is not understood.
The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets.